Vericel appoints CMO: 3 details

Dr. Jonathan Hopper joined Vericel Corp., as the company’s new CMO.

Advertisement

Here are 3 things to know:

1. Dr. Hopper formerly served as senior medical director for orthopedic clinical development at Ferring Pharmaceuticals.

2. Prior to joining Ferring Pharmaceuticals, Dr. Hopper was vice president and global medical director for Stryker.

3. Dr. Hopper earned his MBA from Keele University in Staffordshire, U.K., and his bachelors of medicine degree from Birmingham University Medical School U.K.

More articles on biologics:
Paragon 28 launches bone graft harvesting system for foot and ankle: 4 insights
BioRestorative Therapies publishes study examining stem cell treatment for DDD
Steadman Philippon Research Institute to host Vail Scientific Summit: 4 things to know

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in Biologics

Advertisement

Comments are closed.